227 related articles for article (PubMed ID: 32461206)
1. A pilot study of tofacitinib for refractory Behçet's syndrome.
Liu J; Hou Y; Sun L; Li C; Li L; Zhao Y; Zeng X; Zhang F; Zheng W
Ann Rheum Dis; 2020 Nov; 79(11):1517-1520. PubMed ID: 32461206
[No Abstract] [Full Text] [Related]
2. Correspondence on 'A pilot study of tofacitinib for refractory Behçet's syndrome'.
Zou J; Lin CH; Wang Y; Shen Y; Guan JL
Ann Rheum Dis; 2023 Apr; 82(4):e100. PubMed ID: 33495153
[No Abstract] [Full Text] [Related]
3. Response to: 'Correspondence on 'A pilot study of tofacitinib for refractory Behçet's syndrome'' by Zou
Liu J; Zhao C; Zheng W
Ann Rheum Dis; 2023 Apr; 82(4):e101. PubMed ID: 33495151
[No Abstract] [Full Text] [Related]
4. Efficacy of tofacitinib in synovitis, acne, pustulosis, hyperostosis and osteitis syndrome: a pilot study with clinical and MRI evaluation.
Li Y; Huo J; Cao Y; Yu M; Zhang Y; Li Z; Li C; Zhang W
Ann Rheum Dis; 2020 Sep; 79(9):1255-1257. PubMed ID: 32332076
[No Abstract] [Full Text] [Related]
5. Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients.
Liu LY; Craiglow BG; King BA
J Am Acad Dermatol; 2018 Feb; 78(2):403-404.e1. PubMed ID: 29108908
[No Abstract] [Full Text] [Related]
6. A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo.
McKesey J; Pandya AG
J Am Acad Dermatol; 2019 Aug; 81(2):646-648. PubMed ID: 31009664
[No Abstract] [Full Text] [Related]
7. Gastrointestinal: Refractory parastomal ulcers of Behcet's disease responsive to tofacitinib.
Lin M; Tang J; Huang Z; Gao X; Chao K
J Gastroenterol Hepatol; 2023 Apr; 38(4):485. PubMed ID: 36183336
[No Abstract] [Full Text] [Related]
8. Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome.
Liu S; Li C; Tang MW; Xu WS; Chen KQ; Sui X; Tian XL; Xu KF
Chin Med J (Engl); 2019 Oct; 132(19):2378-2379. PubMed ID: 31503058
[No Abstract] [Full Text] [Related]
9. Tofacitinib for the treatment of recalcitrant palmoplantar pustulosis: A case report.
Haynes D; Topham C; Hagstrom E; Greiling T
Australas J Dermatol; 2020 Feb; 61(1):e108-e110. PubMed ID: 31318041
[No Abstract] [Full Text] [Related]
10. A case of Takayasu arteritis complicated by refractory ulcerative colitis successfully treated with tofacitinib.
Sato S; Matsumoto H; Temmoku J; Fujita Y; Matsuoka N; Furuya M; Gunji N; Fujiwara T; Asano T; Onizawa M; Kobayashi H; Watanabe H; Ohira H; Migita K
Rheumatology (Oxford); 2020 Jul; 59(7):1773-1775. PubMed ID: 31776552
[No Abstract] [Full Text] [Related]
11. Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis.
Kuwabara S; Tanimura S; Matsumoto S; Nakamura H; Horita T
Ann Rheum Dis; 2020 Aug; 79(8):1125-1126. PubMed ID: 32213500
[No Abstract] [Full Text] [Related]
12. Tofacitinib-induced remission in refractory adult-onset Still's disease complicated by macrophage activation syndrome.
Honda M; Moriyama M; Kondo M; Kumakura S; Murakawa Y
Scand J Rheumatol; 2020 Jul; 49(4):336-338. PubMed ID: 32329389
[No Abstract] [Full Text] [Related]
13. Alopecia universalis. Partial response to tofacitinib.
Ruiz-Villaverde R; Cuenca-Barrales C; Linares-Gonzalez L; Ródenas-Herranz T
Med Clin (Barc); 2019 Aug; 153(3):e15. PubMed ID: 30718001
[No Abstract] [Full Text] [Related]
14. Tofacitinib rapidly ameliorated polyarthropathy in a patient with systemic sclerosis.
Komai T; Shoda H; Hanata N; Fujio K
Scand J Rheumatol; 2018 Nov; 47(6):505-506. PubMed ID: 29260607
[No Abstract] [Full Text] [Related]
15. Topical tofacitinib in treatment of alopecia areata.
Ferreira SB; Ferreira RB; Scheinberg MA
Einstein (Sao Paulo); 2020; 18():eAI5452. PubMed ID: 32785452
[No Abstract] [Full Text] [Related]
16. Rapid Repigmentation of Vitiligo Using Tofacitinib Plus Low-Dose, Narrowband UV-B Phototherapy.
Kim SR; Heaton H; Liu LY; King BA
JAMA Dermatol; 2018 Mar; 154(3):370-371. PubMed ID: 29387870
[No Abstract] [Full Text] [Related]
17. Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis.
Dhayalan A; King BA
JAMA Dermatol; 2016 Apr; 152(4):492-3. PubMed ID: 26630079
[No Abstract] [Full Text] [Related]
18. Tofacitinib as a novel salvage therapy for refractory T-cell large granular lymphocytic leukemia.
Bilori B; Thota S; Clemente MJ; Patel B; Jerez A; Afable Ii M; Maciejewski JP
Leukemia; 2015 Dec; 29(12):2427-9. PubMed ID: 26449659
[No Abstract] [Full Text] [Related]
19. Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman.
Mrowietz U; Gerdes S; Gläser R; Schröder O
Acta Derm Venereol; 2017 Feb; 97(2):283-284. PubMed ID: 27349217
[No Abstract] [Full Text] [Related]
20. XELJANZ (Tofacitinib) for Chronic Plaque Psoriasis.
Gupta AK; Daigle D; Abramovits W; Vincent KD
Skinmed; 2015; 13(3):227-9. PubMed ID: 26380510
[No Abstract] [Full Text] [Related]
[Next] [New Search]